-
EP1685841
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1685841
| EP1685841 - Prevention and treatment of thromboembolic disorders [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 04.04.2008 Database last updated on 16.11.2024 | Most recent event Tooltip | 04.04.2008 | Application deemed to be withdrawn | published on 07.05.2008 [2008/19] | Applicant(s) | For all designated states Bayer Health Care Aktiengesellschaft 51368 Leverkusen / DE | [2006/31] | Inventor(s) | 01 /
Misselwitz, Frank Dr. Wielandtstr. 15 69120 Heidelberg / DE | 02 /
Kubitza, Dagmar Dr. Hegelstr. 40 40882 Ratingen / DE | 03 /
Park, Son-Mi Dr. Giveonstr. 21 42287 Wuppertal / DE | 04 /
Wehling, Klaus Dr. Am Rohm 121 42113 Wuppertal / DE | [2006/31] | Application number, filing date | 05001893.6 | 31.01.2005 | [2006/31] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP1685841 | Date: | 02.08.2006 | Language: | EN | [2006/31] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 11.08.2005 | Classification | IPC: | A61K31/5377, A61P7/02, A61P9/10 | [2006/31] | CPC: |
A61K31/00 (EP,NO,US);
A61K31/5377 (EP,KR,NO,US);
A61P7/00 (EP);
A61P7/02 (EP,NO);
A61P9/00 (EP,NO);
A61P9/08 (EP);
A61P9/10 (EP)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/31] | Title | German: | Prophylaxe und Behandlung von thrombolischen Erkrankungen | [2006/31] | English: | Prevention and treatment of thromboembolic disorders | [2006/31] | French: | Prevention et traitement de troubles thromboemboliques | [2006/31] | Examination procedure | 02.02.2007 | Examination requested [2007/12] | 26.04.2007 | Despatch of a communication from the examining division (Time limit: M06) | 07.11.2007 | Application deemed to be withdrawn, date of legal effect [2008/19] | 20.12.2007 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2008/19] | Fees paid | Renewal fee | 31.01.2007 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 31.01.2008 | 04 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XD]US2003153610 (STRAUB ALEXANDER [DE], et al) [XD] 1-8 * paragraphs [0003] , [0008] - [0011] - [0356] , [0366] , [0367] , [0373]; example 44; claims 10-15 *; | [XD] - KUBITZA DAGMAR ET AL, "Multiple dose escalation study investigating the pharmacodynamics, safety, and pharmacokinetics of BAY 59-7939 an oral, direct Factor Xa inhibitor in healthy male subjects.", BLOOD, & 45TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF HEMATOLOGY; SAN DIEGO, CA, USA; DECEMBER 06-09, 2003, (20031116), vol. 102, no. 11, ISSN 0006-4971, page 811a, XP009050847 [XD] 1-8 * abstract * | [X] - KUBITZA DAGMAR ET AL, "Single dose escalation study investigating the pharmacodynamics, safety, and pharmacokinetics of BAY 59-7939 an oral, direct factor Xa inhibitor in healthy male subjects.", BLOOD, & 45TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF HEMATOLOGY; SAN DIEGO, CA, USA; DECEMBER 06-09, 2003, (20031116), vol. 102, no. 11, ISSN 0006-4971, page 813a, XP009050848 [X] 1-8 * abstract * |